Richard B Hynson

Title: Richard B Hynson: Innovator in Bio-Active Compounds and Muscle Enhancement

Introduction

Richard B Hynson is a notable inventor based in Missoula, MT (US). He has made significant contributions to the field of bio-active compounds and muscle enhancement through his innovative patents. With a total of 3 patents, Hynson's work focuses on the extraction and application of amino acids and other compounds for health benefits.

Latest Patents

Hynson's latest patents include methods for deriving, isolating, and/or extracting amino acid compositions from Fenugreek seed. This invention is directed towards novel compositions of bio-active compounds that include 4-hydroxyisoleucine and various amino acids. The compositions are designed to contain between about ten percent and about seventy percent of 4-hydroxyisoleucine, along with other essential amino acids.

Another significant patent is for a method of increasing muscle mass and strength through the administration of adenosine triphosphate (ATP). This invention focuses on compositions that enhance intracellular and extracellular ATP concentrations in mammals, thereby improving anaerobic exercise capacity. The ATP compositions may be combined with various nutrients and administered in different dosage forms to maximize their effectiveness.

Career Highlights

Throughout his career, Richard B Hynson has worked with companies such as TSI Health Sciences, Inc. and TSI Group Limited. His experience in these organizations has contributed to his expertise in developing innovative health-related products.

Collaborations

Hynson has collaborated with notable individuals in his field, including Steve S Lee and Ke-Qin Zhang. These partnerships have likely enriched his research and development efforts.

Conclusion

Richard B Hynson is a distinguished inventor whose work in bio-active compounds and muscle enhancement has the potential to impact health and fitness significantly. His innovative patents reflect a commitment to advancing knowledge in these areas.